Compound Cyclophosphamide Tablets Application Scope

Compound Cyclophosphamide Tablets are indicated for use in malignant tumours, multiple myeloma, lymphoblastic leukemia, neuroblastoma, ovarian cancer, breast cancer, sarcoma and lung cancer.

compound cyclophosphamide tablets

Compound Cyclophosphamide Tablets Characteristics

Ingredients:Compound Cyclophosphamide 50mg, Ginseng Stem and Leaf Saponin 50mg.

Characteristics: Treatment of malignant tumors, multiple myeloma

Specification: Cyclophosphamide 50mg, Ginseng stem and leaf saponin 50mg.

Packing: Aluminum-plastic blister package, 12 tablets×2 plates/box

Storage: Shielded from light, sealed and kept under 30℃.

Expiry date: 24 months

Executive Standard: WS-10001-(HD-0024)-2002

Approval number: State Drug License H12021006

Revision date: According to the latest drug specification.

Manufacturer: Tianjin Jinshi Pharmaceutical Co.

Guidelines For The Use Of Compound Cyclophosphamide Tablets

Dosage and Administration: Oral, adult usual dose: 1 tablet once, 3-4 times a day.

Adverse reactions: myelosuppression is the most common toxicity, leukocytes tend to be the lowest in 10-14 days after administration, mostly return to normal on the 21st day, thrombocytopenia is less common than other alkylating agents; common side effects include nausea, vomiting. The severity is dose-related. Metabolites of cyclophosphamide can produce severe hemorrhagic cystitis, which can be avoided by extensive fluid replacement.

Compound Cyclophosphamide Tablets Medication Limitations

Contraindications: Contraindicated in pregnant and lactating women.

Precautions: Use with caution: bone marrow suppression, history of gout, (Gout is also known as hyperuricemia, purine metabolism disorder, belongs to a kind of arthritis. Gout is a disorder of the metabolism of purine substances in the body, uric acid synthesis increases or discharge decreases, resulting in hyperuricemia, blood uric acid concentration is too high, uric acid in the form of sodium salt deposition in the joints, cartilage and kidneys, resulting in tissue foreign body inflammatory reaction, that is, gout.) Hepatic impairment, infection, renal impairment, tumor cell infiltration of bone marrow, history of urinary stones, previous chemotherapy or radiation therapy.

Compound Cyclophosphamide Tablets Interactions

Cyclophosphamide can increase the serum uric acid level, with the use of anti-gout drugs such as allopurinol, colchicine, probenecid, etc., the dose of anti-gout drugs should be adjusted, so as to control hyperuricemia and gouty disease; allopurinol can increase the myelotoxicity of cyclophosphamide, and the toxicity of cyclophosphamide should be closely observed if co-administration is necessary. Before starting treatment, please inform your doctor of all medications you are using.

Note:

If there is a new packaging for the drug, the new packaging shall prevail. The above information is sourced from HongKong DengYue Medicine, HongKong Drug Wholesale Distributor.
It is only for internal discussion among medical staff and does not serve as a basis for medication. For specific medication guidelines, please consult the attending physician.